JOYN Advisors’s Immunogen Inc IMGN Stock Holding History

JOYN Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-18	Closed	–	–	1520
2018 Q4	$0	Hold	18	–	–	﹤0.01%	1902
2018 Q3	$0	Hold	18	–	–	﹤0.01%	1923
2018 Q2	$0	Buy	+18	New	+$190	﹤0.01%	1889

Other funds holding IMGN

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JOYN Advisors's IMGN Position: Q1 2019 in Review

JOYN Advisors sold out of Immunogen Inc (IMGN) in Q1 2019, closing a stake of 18 shares.

JOYN Advisors first reported a position in IMGN in Q2 2018 and held it in 3 quarters. The position peaked at $0 in Q4 2018. 212 funds tracked by Wall St. Rank hold IMGN as of Q1 2019.

JOYN Advisors reported no remaining Immunogen Inc position as of Q1 2019 after selling out during the quarter.
JOYN Advisors sold 18 Immunogen Inc shares in Q1 2019.
JOYN Advisors first reported a position in Immunogen Inc in Q2 2018 and held it in 3 quarters.
JOYN Advisors's Immunogen Inc position peaked at $0 in Q4 2018.
212 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2019.

Based on JOYN Advisors's 13F filing for Q1 2019, filed 9 May 2019.